Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Heparin Problems Reported in Germany

Adverse reactions similar to those in U.S., but product source is different, FDA says

By Steven Reinberg
HealthDay Reporter


Related Encyclopedia
 border=
Acidophilus
Allergic Rhinitis
Allergies
Allergies To Animals In Children
More...

Related Healthscout Videos
 border=
The On-X Valve PROACT Trial
The On-X Heart Valve: Longevity With Less Reliance on Coumadin
Tissue Valves vs. Mechanical Valves
What is the difference between heart valve repair and replacement?
More...

Related Animations
 border=
Allergy
Alzheimer's Disease Video Animation
Angioplasty
Coronary Bypass Surgery
More...

Related Drug Information
 border=
Accupril
Actonel
Allegra
Allegra D
More...

Related News Articles
 border=
School Lunches Too Fatty and Sugary, Critics Say
Health Tip: Coping With Juvenile Arthritis
Ethnicity May Drive Response to Obesity, Insulin Resistance
Half of Black Teens May Be Vitamin D Deficient
More...

THURSDAY, March 6 (HealthDay News) -- German health officials reported Thursday almost 100 cases of allergic reactions to heparin, a blood-thinning drug that has been blamed for hundreds of allergic reactions and at least four deaths in the United States.

But the German version of the drug is a different brand than the heparin supplied by Illinois-based Baxter Healthcare Corp. that has been linked to the allergic reactions in the United States, primarily among dialysis patients.

Text Continues Below



Following word of the German illnesses, the U.S. Food and Drug Administration said it was urging all U.S. suppliers of heparin to start using sophisticated screening tests to see if their products are free of a contaminant that is the leading suspect in the allergic reactions linked to Baxter's medication.

Baxter gets its main heparin ingredient, which is derived from pig intestines, from China. The heparin made by the German company, Rotexmedica, of Trittau, Germany, comes from a different supplier than the one used by Baxter. No deaths have been reported in Germany, officials said.

The adverse reactions seen in Germany occurred in a dialysis center and included severe allergic reactions and shock, U.S. health officials said.

"German authorities have identified a cluster of events in a dialysis center. They also have a cluster of similar reports from doctors," Dr. Janet Woodcock, acting director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, said during a Thursday afternoon teleconference.

"The heparin active ingredient in that [German] product is not obtained from the same source as the Baxter product," Woodcock added.

It's not yet known if the active ingredient in the German heparin came from China. And it's not known if the German heparin contains the same contaminant found in the Baxter heparin, which is supplied by Scientific Protein Laboratories, of Waunakee, Wisc.

Page:  1 | 2 | 3 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 3/7/2008

Related Links
 border=
From Healthscout's partner site on heart disease, MyHeartCentral.com
Learn about heart disease symptoms.
Get more information on heart disease treatment for your health!
What can you do to prevent heart disease? Prevention details here.





SOURCES: March 6, 2008, teleconference with Janet Woodcock, M.D., acting director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research; March 6, 2008, prepared statement, Scientific Protein Laboratories, of Waunakee, Wisc.


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map